Burning Rock Biotech Ltd reports results for the quarter ended in September - Earnings Summary

Burning Rock Biotech

16/11/2021 14:31

* Burning Rock Biotech Ltd  BNR.OQ  reported a quarterly
adjusted loss of CNY1.64​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for a loss of CNY1.61 per share.
* Revenue rose 2.2% to CNY126.62 million from a year ago; 
analysts expected CNY129.00 million. 
* Burning Rock Biotech Ltd's reported EPS for the quarter was a
loss of CNY1.64​.
* The mean earnings estimate of analysts had fallen by
about 18.4% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Burning Rock Biotech Ltd shares had fallen by 23.1% this
quarter and lost 40.5% so far this year.
* The company reported a quarterly loss of CNY170.48 million.
* Wall Street's median 12-month price target for Burning Rock
Biotech Ltd is $30.95 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 16 at 02:31 p.m.
 ​All figures in Chinese yuan renminbi unless otherwise stated